Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Four out of five UK asthma patients not using pharmacy expertise, study reveals

Practice A study of nine European countries has given the UK one of the lowest rates in western Europe for the use of pharmacists by asthma patients as their main source of information

Just one in five UK asthma patients use pharmacists as a main source of information, an academic study has revealed, one of the lowest rates in western Europe.


Only Finland was lower in its use of pharmacists, where 14 per cent of patients regarded them as a primary source, the study of nine European countries showed.


The survey of 7,457 patients, presented at the annual congress of the European Respiratory Society (ERS) in Barcelona on Wednesday (September 10), found 62 per cent of UK patients used their GP and nearly a third named their nurse as a first port of call. Respondents were asked to choose "their primary source of information about asthma" but could choose more than one source.

More than half of respondents to the survey had not had their inhaler technique checked in the past year

More on asthma

Pharmacy scheme saves more than 170,000 inhalers from landfill

5 quick tips for respiratory MURs

Boots asthma service helps patients take control

Use of pharmacists was highest in Austria at 31 per cent, found the research, sponsored by Mundipharma and conducted by researchers from Education for Health in Warwick, the University of Groningen and the University of Aberdeen.


Co-author David Price, chair of primary care respiratory medicine at Aberdeen University, told C+D the role of pharmacy had "maybe been less well proven" in the UK. Professor Price suggested the UK could make better use of the sector, and stressed there had been "phenomenal outcomes" achieved in Australia by improving inhaler technique through pharmacies.


Of the 8,000 patients questioned overall, 91 per cent thought their condition was well controlled – a figure that was matched by UK patients.


But only 20 per cent met the Global Initiative for Asthma classification for being controlled, and the authors said levels of control remained "sub-optimal" across Europe.


Just over half of respondents had not had their inhaler technique checked in the past year and quarter had experienced exacerbations that required oral steroid use.



How can UK pharmacists improve their relationship with asthma patients?

Comment below or email us at [email protected] You can also find C+D on Twitter, LinkedIn and Facebook

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD016510

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel